logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On March 9, Le Saunda (00738) spent HK$58,000 to repurchase 200,000 shares.

date
17:23 09/03/2026
avatar
GMT Eight
Larsdan (00738) announced that on March 9, 2026, the company spent 58,000 Hong Kong dollars to repurchase 200,000 shares.
LE SAUNDA (00738) announced on March 9, 2026, that the company will buy back 200,000 shares at a cost of HK$58,000.
Related Articles
China Stock
Victory Giant Technology (300476.SZ) issues H shares and obtains approval from the China Securities Regulatory Commission.
HK Stock
Herbs Group (02593) issues profit warning, expecting a net loss of at least approximately 23 million Hong Kong dollars in 2025, compared to a profit in the same period.
US Stock
Resolve past grudges! Hims & Hers (HIM.US) reaches weight loss drug authorization agreement with Novo Nordisk A/S Sponsored ADR Class B (NVO.US), causing stock price to skyrocket 55% before market opening.
Victory Giant Technology (300476.SZ) issues H shares and obtains approval from the China Securities Regulatory Commission.
China Stock
Herbs Group (02593) issues profit warning, expecting a net loss of at least approximately 23 million Hong Kong dollars in 2025, compared to a profit in the same period.
HK Stock
Resolve past grudges! Hims & Hers (HIM.US) reaches weight loss drug authorization agreement with Novo Nordisk A/S Sponsored ADR Class B (NVO.US), causing stock price to skyrocket 55% before market opening.
US Stock
RECOMMEND
Hong Kong IPOs Start Year With Rapid Pace As Fundraising Jumps Tenfold And No First‑Day Declines
Hong Kong IPOs Start Year With Rapid Pace As Fundraising Jumps Tenfold And No First‑Day Declines
icon
02/03/2026
Hong Kong IPO Cornerstone Investors Have Subscribed HKD 40 Billion This Year
Hong Kong IPO Cornerstone Investors Have Subscribed HKD 40 Billion This Year
icon
02/03/2026
Over One Trillion Market Value Evaporates As Nvidia Reports Strong Results But Shares Plunge
Over One Trillion Market Value Evaporates As Nvidia Reports Strong Results But Shares Plunge
icon
02/03/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.